Literature DB >> 4322162

Pseudomonas bacteremia in patients with malignant diseases.

J P Whitecar, M Luna, G P Bodey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4322162     DOI: 10.1097/00000441-197010000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  19 in total

1.  Primary ecthyma gangraenosum due to central venous catheter-related bloodstream infection with Pseudomonas aeruginosa.

Authors:  Enrico Schalk; Vanja Zeremski; Thomas Fischer
Journal:  Infection       Date:  2018-09-05       Impact factor: 3.553

2.  [Septicemic complications in leukemia and myeloic insufficiency].

Authors:  W Stille
Journal:  Blut       Date:  1973-06

3.  Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime.

Authors:  B E de Pauw; T de Witte; J T Janssen; C Haanen
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

Review 4.  Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.

Authors:  J W Hathorn; M Rubin; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 5.  [Supportive care in bone marrow failure. Technical, immunological and clinical advances].

Authors:  H P Lohrmann; S F Goldmann; W Adam
Journal:  Klin Wochenschr       Date:  1975-07-01

6.  Management of the febrile neutropenic patient.

Authors:  L A Mandell
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

7.  Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.

Authors:  T Meshulam; H A Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-04       Impact factor: 3.267

8.  Pneumonia during the treatment of acute leukaemia.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

9.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

Authors:  H E Gilleland; M G Parker; J M Matthews; R D Berg
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.